{
    "code": "52026999",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026999",
    "time": "2022-04-15 07:12:46",
    "許可證字號": "衛部藥輸字第026999號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/01\/17",
    "發證\/登錄日期": "106\/01\/17",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202699905",
    "中文品名": "痛舒適",
    "英文品名": "Penthrox",
    "適應症": "適用於輕至中度急性疼痛的短期止痛",
    "劑型": "479吸入用液劑",
    "包裝": "3毫升type I(每盒10瓶)玻璃瓶裝 3毫升(每盒1組)type I 玻璃瓶及吸入器,附活性碳 3毫升(每盒10組)type I 玻璃瓶及吸入器",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "METHOXYFLURANE",
    "限制項目": "02輸　入 1D須執行風險管理計畫 1Q不得輸入",
    "申請商名稱": "6237018867  緯曜國際股份有限公司",
    "申請商地址": "彰化縣彰化市香山里彰南路二段346巷12號",
    "主製造廠": [
        {
            "": "AUSTRALIA",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FAU0103000  MEDICAL DEVELOPMENT INTERNATIONAL LIMITED",
            "製造廠廠址": "4 CARIBBEAN DRIVE, SCORESBY VIC 3179, AUSTRALIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRALIA",
            "製程": "公司"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2804000900",
            "成分名稱": "METHOXYFLURANE",
            "含量描述": "",
            "含量": "99.9000000000",
            "單位": "%"
        }
    ],
    "仿單外盒": [
        {
            "title": "Penthrox 中文仿單V6-108-09-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026999&Seq=003&Type=9"
        },
        {
            "title": "Penthrox藥品風險管理計畫附件1病患醫藥說明書V2-106-02-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026999&Seq=002&Type=9"
        },
        {
            "title": "8321Taiwan oversticker mockup-108-09-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026999&Seq=004&Type=8"
        },
        {
            "title": "8321Taiwan Combi_V3-108-09-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026999&Seq=003&Type=8"
        },
        {
            "title": "8321MDI Taiwan Single combination pack_V3-108-09-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026999&Seq=002&Type=8"
        },
        {
            "title": "8321MDI Taiwan 3ml 10 pack_V3-108-09-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026999&Seq=001&Type=8"
        }
    ]
}